Kabra Drugs Ltd.
BSE: 524322 | Sector: Health care |
NSE: N.A. | ISIN Code: INE323K01017 |
BSE 00:00 | 27 Jan | 4.18 |
0 (0.00%) |
OPEN
4.50 |
HIGH
4.50 |
LOW
4.18 |
NSE 05:30 | 01 Jan | Kabra Drugs Ltd |
OPEN | 4.50 |
PREVIOUS CLOSE | 4.18 |
VOLUME | 205 |
52-Week high | 5.70 |
52-Week low | 2.95 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Kabra Drugs Ltd. (KABRADRUGS) - BULK DEALS
DATE | CLIENT NAME | EXCHANGE | TRANSACTION | QUANTITY | PRICE |
03-09-2020 | KOTHARI VINOD FOJMALJI | BSE | BUY | 30000 | 2.73 |
08-06-2020 | P B PRADEEP . | BSE | BUY | 48947 | 3.73 |
08-06-2020 | LAVEKUSH GADIYA | BSE | SELL | 28124 | 3.72 |
01-06-2020 | P B PRADEEP . | BSE | BUY | 44485 | 3.77 |
23-03-2020 | ANUPRIYA SUREKH | BSE | BUY | 88368 | 2.82 |
23-03-2020 | NANDKISHOR SIMAYA | BSE | SELL | 88368 | 2.82 |
11-02-2020 | M Y THULASI MANI | BSE | BUY | 36000 | 1.84 |
11-02-2020 | AATUR BAKLIWAL | BSE | SELL | 62374 | 1.84 |
11-02-2020 | ROOPCHAND JAIN HUF | BSE | SELL | 31000 | 1.84 |
11-02-2020 | SHILPA SATISH | BSE | BUY | 50000 | 1.84 |
11-02-2020 | LAVEKUSH GADIYA | BSE | SELL | 26192 | 1.84 |
31-01-2020 | VINAY KUMAR V | BSE | BUY | 58000 | 1.37 |
31-01-2020 | AATUR BAKLIWAL | BSE | SELL | 230000 | 1.40 |
31-01-2020 | MANJUNATH B R | BSE | BUY | 36475 | 1.43 |
31-01-2020 | K SATISH | BSE | BUY | 70750 | 1.41 |
31-01-2020 | ROOPCHAND JAIN HUF | BSE | BUY | 31000 | 1.43 |
24-01-2020 | RAHUL ANANTRAI MEHTA | BSE | BUY | 69660 | 1.15 |
24-01-2020 | SHILPA KUMAR | BSE | SELL | 68450 | 1.15 |
21-01-2020 | RAMACHANDRAN MURALIDHARAN | BSE | SELL | 43349 | 1.04 |
21-01-2020 | ARTHI | BSE | BUY | 43349 | 1.04 |
Quick Links for Kabra Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices